Abstract：ObjectiveTo compare the acute adverse reactions of same period chemotherapy of VMAT and IMRT after colorectal cancer surgery,and to explore the clinical application value of the same period VMAT chemotherapy.Methods50 patients with locally advanced rectal cancer(stage T2-T4or N+)from July 2010 to January 2017 in Meizhou People′s Hospital were selected as the research object,according to the different ways of treatment,they were divided into VMAT group(n=20)and IMRT group(n=30).Patients of the VMAT group were given the treatment of VMAT combined with Capecitabine at the same period,patients of the IMRT group were given the treatment of IMRT combined with Capecitabine at the same period.The same chemotherapy regimens of Capecitabine was 825 mg/m2,2 times per day, 5 times per week.Adjuvant chemotherapy for 8-10 times of improved FOLFOX6 scheme.Acute adverse reactions of patients of two groups during treatment,such as skin mucous membrane,digestive tract,urinary tract and hematologic system were compared.ResultsAll patients of the VMAT group completed the operation,and 3 cases of the IMRT group could not tolerate the adverse reactions and terminated the radiation.The most common adverse reactions of patients in the two groups were digestive tract,upper gastrointestinal tract,skin and mucosa reaction and response in sequence;the incidence of levelsⅡ-Ⅳdigestive tract in the IMRT group was significantly higher than that of VMAT group(P<0.05). In the two groups in the reaction of skin mucous membrane,urinary system,upper gastrointestinal tract,and bone marrow suppression such as leukopenia,decreased platelet and anemia had no significant difference (P>0.05).ConclusionPostoperative rectal cancer same period chemotherapy of VMAT combined with Capecitabine has a lower incidence of acute adverse reactions,compared with IMRT combined with Capecitabine can significantly reduce the severe gastrointestinal reaction,and with good tolerance.
罗敬;李国强;郑志坚;叶玲;徐玉云;刘雅胜;杨泉富. 直肠癌术后VMAT同期化疗与IMRT同期化疗的急性不良反应比较[J]. 中国当代医药, 2017, 24(11): 71-74转77.
LUO Jing;LI Guo-qiang;ZHENG Zhi-Jian;YE Ling XU;Yu-yun;LIU Ya-sheng;YANG Quan-fu. Comparison of the acute adverse reactions of same period chemotherapy of VMAT and IMRT after colorectal cancer surgery. 中国当代医药, 2017, 24(11): 71-74转77.
O’Connell MJ，Colangelo LH，Beart RW，et al.Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer：surgical end points from National Surgical Adjuvant and Bowel Project trial R-04[J].J Clin Oncol，2014，32（18）：1927-1934.
Rodel C，Graeven U，Fietkau R，et al.Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer（the German CAO/ARO/AIO-04 study）：final results of the multicentre，open-label，randomised，phase 3 trial[J].Lancet Oncol，2015，16（8）：979-989.
[8]
Siegel R，Desantis C，Jemal A.Colorectal cancer statistics[J]. CA Cancer J Clin，2014，64（2）：104-117.
[9]
Shi HS，Gao X，Li D，et al.A systematic administration of liposomal eurcumin inhibits radiation pneumonitis and sensitizeslung carcinoma to radiation[J].Int J Naomedic，2012，7（2）：2601-2611.
[10]
Yang CW，Chang CL，Lee HC，et al.Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways[J].BMC Complement Chem Med，2012，12（4）：22.
[11]
Takebe N，Warren RQ，Ivy SP.Breast cancer growth and metastasis：interplay between cancer stem cells，embryonic signaling pathways and epithelial-to-mesenchymal transition[J].Breast Cancer Res，2011，13（3）：211-220.
[12]
Miller ED，Robb BW，Cummings OW，et al.The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer[J].Dis Colon Rectum，2012，55（9）：1002-1007.
[13]
Valent P，Bonnet D，DeMaria R，et al.Cancer stem cell definitions and terminology：the devil is in the details[J]. Nat Rev Cancer，2012，12（11）：767-775.
Kinjo T，Nonomura D，Yamamoto Y，et al.Primary adenocarcinoma of the seminal vesicle difficult to differentiate from rectal carcinoma：a case report[J].Hinyokika Kiyo，2013，59（9）：597-601.
[18]
Wang L，Zhang X，Li Z，et al.Overexpression of nuclear beta-catenin at invasive front in rectal carcinoma is associated with lymph node metastasis and poor prognosis[J]. Clin Transl Oncol，2014，16（5）：488-494.
[19]
Ahn MH，Bae KB，Kwon JA，et al.Association of MUC6-minisatellite variants with susceptibility to rectal carcinoma[J].Mol Biol Rep，2013，40（1）：303-308.
[20]
Hoeffel C，Mule S，Laurent V，et al.Current imaging of rectal cancer[J].Clin Res Hepatol Gastroenterol，2015，39（2）：168-173.
京公网安备 11010502046607号